122 related articles for article (PubMed ID: 36404199)
1. Chronological improvement of pancreatectomy for resectable but advanced pancreatic neuroendocrine neoplasms.
Takamoto T; Nara S; Ban D; Mizui T; Murase Y; Esaki M; Shimada K
Pancreatology; 2022 Dec; 22(8):1141-1147. PubMed ID: 36404199
[TBL] [Abstract][Full Text] [Related]
2. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Significance of Lymphatic, Microvascular and Perineural Invasion in Patients With Pancreatic Neuroendocrine Neoplasms.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Matsunaga Y; Shiihara M; Takayama Y; Tahara J; Shimizu K; Tokushige K; Yamamoto M
Cancer Diagn Progn; 2022; 2(2):150-159. PubMed ID: 35399168
[TBL] [Abstract][Full Text] [Related]
5. Pancreatectomy with Mesenteric and Portal Vein Resection for Borderline Resectable Pancreatic Cancer: Multicenter Study of 406 Patients.
Ramacciato G; Nigri G; Petrucciani N; Pinna AD; Ravaioli M; Jovine E; Minni F; Grazi GL; Chirletti P; Tisone G; Napoli N; Boggi U
Ann Surg Oncol; 2016 Jun; 23(6):2028-37. PubMed ID: 26893222
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumor-to-parenchymal contrast enhancement ratio on portal venous-phase CT in pancreatic neuroendocrine neoplasms.
Park HJ; Kim HJ; Kim JH; Kim SY; Choi SH; Byun JH; Kim SC; Hwang HS; Hong SM
Eur Radiol; 2023 Apr; 33(4):2713-2724. PubMed ID: 36378252
[TBL] [Abstract][Full Text] [Related]
7. Surgical Principles in the Management of Pancreatic Neuroendocrine Neoplasms.
Andreasi V; Muffatti F; Guarneri G; Falconi M; Partelli S
Curr Treat Options Oncol; 2020 Apr; 21(6):48. PubMed ID: 32350693
[TBL] [Abstract][Full Text] [Related]
8. Reassessment of the clinical significance of portal-superior mesenteric vein invasion in borderline resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Wakamatsu S; Hoshi S; Hoshi N; Hirabayashi K; Ogata Y
Eur J Surg Oncol; 2017 Jun; 43(6):1068-1075. PubMed ID: 28427822
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Recurrence Between Pancreatic and Duodenal Neuroendocrine Neoplasms After Curative Resection: A Single-Institution Analysis.
Masui T; Sato A; Nakano K; Uchida Y; Yogo A; Anazawa T; Nagai K; Kawaguchi Y; Takaori K; Uemoto S
Ann Surg Oncol; 2018 Feb; 25(2):528-534. PubMed ID: 29164413
[TBL] [Abstract][Full Text] [Related]
10. The Role of Perioperative Systemic Therapy in Localized Pancreatic Neuroendocrine Neoplasms.
Xie H; Liu J; Yadav S; Keutgen XM; Hobday TJ; Strosberg JR; Halfdanarson TR
Neuroendocrinology; 2020; 110(3-4):234-245. PubMed ID: 31121586
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after distal pancreatectomy for neuroendocrine neoplasms: a retrospective comparison between minimally invasive and open approach using propensity score weighting.
Partelli S; Andreasi V; Rancoita PMV; Perez-Sanchez E; Muffatti F; Balzano G; Crippa S; Di Serio C; Falconi M
Surg Endosc; 2021 Jan; 35(1):165-173. PubMed ID: 31953734
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Analysis of Distal Pancreatectomy for Pancreatic Body and/or Tail Cancer Involving the Portal Vein: Is Pancreatic Body and/or Tail Cancer Involving the Portal Vein Resectable?
Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Aramaki T; Notsu A; Uesaka K
Pancreas; 2022 May; 51(5):502-509. PubMed ID: 35835102
[TBL] [Abstract][Full Text] [Related]
13. Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors.
Prakash L; Lee JE; Yao J; Bhosale P; Balachandran A; Wang H; Fleming JB; Katz MH
J Gastrointest Surg; 2015 Nov; 19(11):2011-8. PubMed ID: 26282850
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
Birnbaum DJ; Turrini O; Vigano L; Russolillo N; Autret A; Moutardier V; Capussotti L; Le Treut YP; Delpero JR; Hardwigsen J
Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
[TBL] [Abstract][Full Text] [Related]
15. Pancreatectomy With Arterial and Portal Vein Reconstruction for Locally Advanced Pancreatic Cancer - A Case Report and Literature Review.
Brasoveanu V; Romanescu D; Barbu I; Balescu I; Bacalbasa N
In Vivo; 2020; 34(5):2791-2795. PubMed ID: 32871816
[TBL] [Abstract][Full Text] [Related]
16. Results of pancreatic resection associated with portal vein resection in an Australian tertiary care centre.
Iorgulescu DG; Ling S; Nikfarjam M; Fink MA; Jones R; Muralidharan V; Starkey G; Christophi C
ANZ J Surg; 2015 Apr; 85(4):270-3. PubMed ID: 24712309
[TBL] [Abstract][Full Text] [Related]
17. Successful pancreatectomy with en-bloc resection of the celiac artery and portal vein for pancreatic endocrine carcinoma.
Akatsu T; Aiura K; Shimazu M; Ueda M; Wakabayashi G; Tanabe M; Kawachi S; Shinoda M; Kameyama K; Kitajima M; Kitagawa Y
Hepatogastroenterology; 2007 Jun; 54(76):1269-71. PubMed ID: 17629086
[TBL] [Abstract][Full Text] [Related]
18. Long term results of pancreatectomy with portal-superior mesenteric vein resection for pancreatic carcinoma: a systematic review.
Tang D; Zhang JQ; Wang DR
Hepatogastroenterology; 2011; 58(106):623-31. PubMed ID: 21661443
[TBL] [Abstract][Full Text] [Related]
19. Utility of contrast-enhanced harmonic endoscopic ultrasonography for predicting the prognosis of pancreatic neuroendocrine neoplasms.
Ishikawa R; Kamata K; Hara A; Tanaka H; Okamoto A; Yamazaki T; Nakai A; Omoto S; Minaga K; Yamao K; Takenaka M; Minami Y; Watanabe T; Chiba Y; Chikugo T; Matsumoto I; Takeyama Y; Matsukubo Y; Hyodo T; Kudo M
Dig Endosc; 2021 Jul; 33(5):829-839. PubMed ID: 33020955
[TBL] [Abstract][Full Text] [Related]
20. The clinical impact of portal venous patency ratio on prognosis of patients with pancreatic ductal adenocarcinoma undergoing pancreatectomy with combined resection of portal vein following preoperative chemoradiotherapy.
Jaseanchiun W; Kato H; Hayasaki A; Fujii T; Iizawa Y; Tanemura A; Murata Y; Azumi Y; Kuriyama N; Kishiwada M; Mizuno S; Usui M; Sakurai H; Isaji S
Pancreatology; 2019 Mar; 19(2):307-315. PubMed ID: 30738764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
